Inflammation Startup Bionyra Launches With $165M and Ex-Sanofi Exec at the Helm – MedCity News
As a Sanofi veteran, Frédéric Marrache is well aware of the innovations shaping immunology. His tenure there came as Dupixent…
As a Sanofi veteran, Frédéric Marrache is well aware of the innovations shaping immunology. His tenure there came as Dupixent…
StageOne Closes Fifth Fund StageOne Ventures has announced the closing of its fifth fund at $165 million. The milestone marks…